10 (Tadalafil Tablets Usp 1)
Tadalafil Tablet, Film Coated
Product Images NDC 60219-1349
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 60219-1349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
2.5 mg Label (Tadalafil Tablets Usp 10)
Tadalafil Tablets, USP are for once daily use and come in a bottle containing 30 tablets. Each tablet should be taken as an entire dose and should not be split. The usual dosage should be determined by the accompanying literature. The tablets contain 2.6 mg of Tadalafil, USP and should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It should be kept out of reach of children and distributed in a tight container. This medication is distributed by Amneal Pharmaceuticals LLC. Lot and expiration date information is available in the non-varnish area.*
5 mg Label (Tadalafil Tablets Usp 11)
This is a description of Tadalafil tablets, with the product details and dosage information. The tablets come in a film coating and should not be split. It is an Rx-only medication and must be taken as prescribed. The tablet contains 5mg of Tadalafil, USP, and has specific storage instructions. The medication should be kept in a tight container and out of reach of children. This medication is distributed by Amneal Pharmaceuticals LLC. The Lot and Exp. Date is printed in a non-varnish area.*
10 mg (Tadalafil Tablets Usp 12)
This is a medication with NDC 60219-1348-3 used for treating erectile dysfunction containing Tadalafil. The usual dosage is provided in the accompanying literature. The tablets should be stored between 20°C to 25°C and should not be split. It is an Rx-only medication that needs to be kept out of reach of children and dispensed in a tight container. The medication is distributed by Amneal Pharmaceuticals LLC from Bridgewater, NJ. Lot and expiration dates are provided in a non-varnish area.*
20 mg Label (Tadalafil Tablets Usp 13)
This is a description of Tadalafil Tablets, USP, a medication distributed by Amneal Pharmaceuticals LLC. The tablets should not be split and the entire dose should be taken. Each film-coated tablet contains 20mg of Tadalafil, USP, and the usual dosage should be confirmed with accompanying literature. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. The medication should be kept in a secure container, away from children. The accompanying packaging includes the lot and expiration date.*
10 (Tadalafil Tablets Usp 2)
This appears to be part of a table or graph showing the difference in blood pressure between tadalafil and placebo in a clinical trial. The text contains measurements of standing and supine systolic and diastolic blood pressure in millimeters of mercury (mmHg) over a period of time (in hours). However, without more context or additional information, it is difficult to provide further analysis or interpretation.*
10 (Tadalafil Tablets Usp 3)
10 (Tadalafil Tablets Usp 4)
10 (Tadalafil Tablets Usp 5)
This is a graph showing the concentration of plasma tadalafil in mcg/L over time in hours. It compares the concentration levels after a single 20-mg dose, a single 5-mg dose, and a once-daily 5-mg dose following 5 consecutive days of administration. The concentration levels range from 0 to 500 mcg/L.*
10 (Tadalafil Tablets Usp 6)
The text provides information about the change from the baseline in IPSS (International Prostate Symptom Score) total score. There are two treatments compared: Tadalafil 5 mg and Placebo, with a statistically significant difference between them (p<0.01). However, there is no information about the duration of the treatment.*
10 (Tadalafil Tablets Usp 7)
This is a clinical trial study comparing the effects of Tadalafil 5mg with a placebo on IPSS (International Prostate Symptom Score) total score. There is a statistically significant difference between the two treatments (p<0.01). The duration of treatment is not available.*
10 (Tadalafil Tablets Usp 8)
Not available.*
10 (Tadalafil Tablets Usp 9)
The text presents the results of a study comparing the effects of Tadalafil 5mg and Placebo on IPSS Total Score, a measure of prostate enlargement. The treatment duration is not available. The study indicates that there is a significant difference between the two groups (p<0.01) regarding their change from baseline in IPSS Total Score.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
